Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Serina Therapeutics, Inc.US flagNew York Stock Exchange American
1.79
USD
+0.03
- -
19.39MMarket Cap

Income Statement (USD)

APIChat
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
3
- -
3
- -
- -
+ Sales & Services Revenue
3
- -
3
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
-3
- -
-3
- -
- -
- Operating Expenses
5
3
6
17
24
+ Selling, General & Admin
1
1
4
10
11
+ Research & Development
4
2
2
7
13
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-2
-2
-3
-17
-24
- Non-Operating (Income) Loss
- -
- -
-8
-6
-5
+ Interest Expense, Net
- -
- -
1
1
- -
+ Interest Expense
- -
- -
1
1
- -
- Interest Income
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
-9
-6
-5
Pretax Income
-1
-3
5
-11
-19
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-3
5
-11
-19
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-3
5
-11
-19
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-3
5
-11
-19
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-3
5
-11
-19
EBIT
-2
-2
-3
-17
-24
EBITDA
-2
-2
-3
-17
-24
EBITDA Margin (%)
-52.58
-441.82
-101.3
- -
- -
EBITA
-2
-2
-3
-17
-24
Gross Margin (%)
100
100
100
100
- -
Operating Margin (%)
-53.68
-454.07
-104.3
- -
- -
Profit Margin (%)
-41.61
-536.42
175.63
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
2
2
8
7
10
Basic EPS, GAAP
-0.58
-1.23
0.63
-1.51
-1.88
Basic EPS from Cont Ops
-0.58
-1.23
0.63
-1.52
-1.89
Diluted Weighted Avg Shares
8
8
8
7
10
Diluted EPS, GAAP
-0.17
-0.36
0.63
-1.51
-1.88
Diluted EPS from Cont Ops
-0.17
-0.36
0.63
-1.52
-1.89

Balance Sheet (USD)

APIChat
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
1
1
8
6
6
+ Cash, Cash Equivalents & STI
1
1
8
4
5
+ Cash & Cash Equivalents
- -
1
8
4
3
+ ST Investments
1
- -
- -
- -
2
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
2
1
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
- -
1
1
1
+ Property, Plant & Equip, Net
1
- -
1
1
1
+ Property, Plant & Equip
1
1
2
2
1
- Accumulated Depreciation
- -
- -
- -
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
Total Assets
2
1
9
7
7
+ Payables & Accruals
- -
- -
1
1
2
+ Accounts Payable
- -
- -
1
1
2
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
1
1
- -
+ ST Debt
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
1
1
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
1
1
Total Current Liabilities
- -
- -
1
2
4
+ LT Debt
- -
2
3
- -
3
+ LT Borrowings
- -
2
3
- -
3
+ LT Finance Leases
- -
- -
- -
- -
- -
+ Other LT Liabilities
36
37
36
4
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
36
37
36
4
- -
Total Noncurrent Liabilities
37
38
40
4
3
Total Liabilities
37
39
41
6
7
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
5
+ Share Capital & APIC
1
1
1
45
59
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
1
1
45
59
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-36
-38
-33
-44
-64
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-35
-38
-32
1
- -
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-35
-38
-32
1
- -
Total Liabilities & Equity
2
1
9
7
7
Shares Outstanding
8
8
8
9
11
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
Net Debt
- -
1
-5
-4
- -
Net Debt to Equity
0.9
-2.87
14.36
-722.83
297.3
Tangible Common Equity Ratio
-1,903.46
-4,402.83
-360.1
7.56
-71.6
Current Ratio
3.58
1.25
5.39
2.4
1.71
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-1
-3
5
-11
-19
+ Depreciation & Amortization
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
-8
-3
- -
+ Stock-Based Compensation
- -
- -
- -
3
4
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
-8
-5
-4
+ Chg in Non-Cash Work Cap
-1
- -
- -
-3
1
+ (Inc) Dec in Accts Receiv
1
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-2
1
+ Inc (Dec) in Accts Payable
- -
- -
- -
-1
1
+ Inc (Dec) in Other
-2
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-2
-2
-2
-17
-18
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
5
8
+ Increase in Capital Stock
- -
- -
- -
5
8
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
1
1
- -
- -
- -
+ Dec in LT Investment
1
1
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
1
1
-1
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
1
10
3
5
+ Cash From Debt
- -
5
10
3
5
+ Repayments of Debt
- -
-4
- -
- -
- -
+ Other Financing Activities
1
- -
- -
5
5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
1
1
10
13
17
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
7
-4
-1
EBITDA
-2
-2
-3
-17
-24
EBITDA Margin (%)
-52.58
-441.82
-101.3
- -
- -
Free Cash Flow
-2
-2
-3
-17
-18
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
-2
- -
- -
Free Cash Flow to Equity
- -
-1
7
-14
-8
Free Cash Flow per Basic Share
-1.08
-0.96
-0.35
-2.33
-1.77
Price/Free Cash Flow
-137.16
-72.01
-58.67
-2.15
-1.09
Cash Flow to Net Income
1.78
0.77
-0.47
1.54
0.94
Capital Expenditures
- -
- -
-1
- -
- -